Concepedia

Michelle L. Dean

ML

25

Publications

1.3K

Citations

18

H-Index

2004

Active since

Affiliations

University of Calgary(Current)

Alberta Health Services

Moffitt Cancer Center

University of British Columbia

Calgary Laboratory Services

Michelle L. Dean is an author at University of Calgary specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2004–2024

25

Publications

25

Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer

Emeka K. Enwere, Elizabeth Kornaga, Michelle L. Dean et al. · Modern Pathology · 2017 · 183 citations · Full text

Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53

Chris T. Williamson, Eiji Kubota, Jeffrey D. Hamill et al. · EMBO Molecular Medicine · 2012 · 125 citations · Full text

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors

Sarah Cook, Vanessa Samuel, Daniel E. Meyers et al. · JAMA Network Open · 2024 · 121 citations · Full text

Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: Leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma

SS Mahmood, Samuel Agresta, Carlos E. Vigil et al. · International Journal of Cancer · 2010 · 111 citations · Full text

, , +16

An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer

David L. Rimm, Samuel Leung, Lisa M. McShane et al. · Modern Pathology · 2018 · 90 citations · Full text

, , +11

Rows per page

1–5 of 25